Benitec Biopharma  logo
Benitec Biopharma BNTC
$ 10.24 -3.94%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Benitec Biopharma Balance Sheet 2011-2024 | BNTC

Annual Balance Sheet Benitec Biopharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-1.92 M -3.25 M - -9.4 M -15.7 M -11.8 M -13.4 M -13.6 M -16.7 M -20.5 M -28.6 M - -

Long Term Debt

- 284 K 559 K - - - - - - - - - - -

Long Term Debt Current

284 K 275 K 252 K 213 K 192 K - - - - - - - - -

Total Non Current Liabilities

- - - - 213 K - 35.3 K 26.9 K 13.4 K - - - - -

Total Current Liabilities

4.92 M 3.98 M 2.53 M 1.37 M 1.14 M - - - - - - - - -

Total Liabilities

4.96 M 4.26 M 3.09 M 1.37 M 1.35 M 2.64 M 1.91 M 891 K 786 K 1.26 M 1.55 M 872 K - -

Deferred Revenue

- - - - - - - - - - - - - -

Retained Earnings

-190 M -181 M -148 M -130 M -117 M -98.9 M -108 M -104 M -98.1 M -82.7 M -101 M -87.9 M - -

Total Assets

52.2 M 4.46 M 5.97 M 21.4 M 11.6 M 19.2 M 15.7 M 17.4 M 14.9 M 19.6 M 24 M 31.5 M - -

Cash and Cash Equivalents

50.9 M 2.48 M 4.06 M 19.8 M 9.8 M 15.7 M - - - - - - - -

Book Value

47.2 M 202 K 2.88 M 20 M 10.2 M 16.6 M 13.8 M 16.5 M 14.1 M 18.3 M 22.5 M 30.6 M - -

Total Shareholders Equity

47.2 M 202 K 2.88 M 20 M 10.2 M 16.6 M - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Benitec Biopharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - 62 K 137 K 211 K 284 K 354 K 422 K 491 K 559 K 635 K 698 K 760 K - - 108 K 161 K 213 K 213 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

4.59 M 4.96 M 3.5 M 5.88 M 4.74 M 4.26 M 3.51 M 2.91 M 3.5 M 3.09 M 2.54 M 3.18 M 2.36 M 1.37 M 1.37 M 887 K 1.18 M 1.35 M 1.35 M - - 2.64 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-195 M -190 M -185 M -181 M -174 M -168 M -163 M -159 M -153 M -148 M -143 M -140 M -135 M -130 M -130 M -122 M -119 M -117 M -117 M - - -109 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

68.8 M 52.2 M 15 M 21.4 M 27.1 M 4.46 M 8.22 M 11.9 M 18.1 M 5.97 M 10.1 M 14 M 17.8 M 21.4 M 21.4 M 15.5 M 8.92 M 11.6 M 11.6 M - - 19.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

67.8 M 50.9 M 14.1 M 20.4 M 25.9 M 2.49 M 6.56 M 10.6 M 16.5 M 4.06 M 8.63 M 12.3 M 15.7 M 19.8 M 19.8 M 14 M 7.45 M 14 M 7.45 M 13.8 M 16.6 M 15.7 M - - - 11.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

64.2 M 47.2 M 11.5 M 15.5 M 22.3 M 202 K 4.71 M 8.99 M 14.6 M 2.88 M 7.52 M 10.8 M 15.5 M 20 M 20 M 14.6 M 7.74 M 10.2 M 10.2 M - - 16.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

64.2 M 47.2 M 11.5 M 15.5 M 22.3 M 202 K 4.71 M 8.99 M 14.6 M 2.88 M 7.52 M 10.8 M 15.5 M 20 M 15.5 M 14.6 M 14.6 M 14.6 M 7.74 M 15.3 M 17 M 16.6 M - - - 13.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency